The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...

The villains were injectable specialty drugs like Keytruda and inpatient surgical procedures for seriously ill patients.

The company announced that the Food and Drug Administration (FDA) has approved Journavx, a twice-daily pill that it described as a "highly selective NaV1.8 pain signal inhibitor for the treatment of ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on Eton Pharmaceuticals (ETON – Research Report) today. The company’s shares ...

Miki Sogi, an analyst from Bernstein, maintained the Hold rating on Takeda Pharmaceutical Co (TKPHF – Research Report). The associated price ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...

At the Senate Finance nomination hearing yesterday, he declined to give a yes-or-no answer about Affordable Care Act tax credit rule renewal.

Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...

An Iowa pharmacy technician who was allegedly captured on video stealing prescription medications from a customer has agreed ...